BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 35253861)

  • 21. netCRS: Network-based comorbidity risk score for prediction of myocardial infarction using biobank-scaled PheWAS data.
    Nam Y; Jung SH; Verma A; Sriram V; Won HH; Yun JS; ; Kim D
    Pac Symp Biocomput; 2022; 27():325-336. PubMed ID: 34890160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring various polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative and the UK Biobank with a visual catalog: PRSWeb.
    Fritsche LG; Beesley LJ; VandeHaar P; Peng RB; Salvatore M; Zawistowski M; Gagliano Taliun SA; Das S; LeFaive J; Kaleba EO; Klumpner TT; Moser SE; Blanc VM; Brummett CM; Kheterpal S; Abecasis GR; Gruber SB; Mukherjee B
    PLoS Genet; 2019 Jun; 15(6):e1008202. PubMed ID: 31194742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome.
    Richardson TG; Harrison S; Hemani G; Davey Smith G
    Elife; 2019 Mar; 8():. PubMed ID: 30835202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan.
    Sakaue S; Kanai M; Karjalainen J; Akiyama M; Kurki M; Matoba N; Takahashi A; Hirata M; Kubo M; Matsuda K; Murakami Y; ; Daly MJ; Kamatani Y; Okada Y
    Nat Med; 2020 Apr; 26(4):542-548. PubMed ID: 32251405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
    Clark K; Leung YY; Lee WP; Voight B; Wang LS
    J Alzheimers Dis; 2022; 89(1):1-12. PubMed ID: 35848019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between polygenic risk score and covid-19 susceptibility and severity across ethnic groups: UK Biobank analysis.
    Farooqi R; Kooner JS; Zhang W
    BMC Med Genomics; 2023 Jun; 16(1):150. PubMed ID: 37386504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals.
    Hartwell EE; Merikangas AK; Verma SS; Ritchie MD; ; Kranzler HR; Kember RL
    Addict Biol; 2022 Jan; 27(1):e13099. PubMed ID: 34611967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations.
    Xin J; Du M; Gu D; Jiang K; Wang M; Jin M; Hu Y; Ben S; Chen S; Shao W; Li S; Chu H; Zhu L; Li C; Chen K; Ding K; Zhang Z; Shen H; Wang M
    Genome Med; 2023 Jan; 15(1):4. PubMed ID: 36694225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
    Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
    Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic risk and causal inference of psychiatric comorbidity in inflammatory bowel disease among patients with European ancestry.
    Li Y; Bernstein CN; Xu W; Hu P
    J Transl Med; 2022 Jan; 20(1):43. PubMed ID: 35086532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.
    Shoaib M; Ye Q; IglayReger H; Tan MH; Boehnke M; Burant CF; Soleimanpour SA; Gagliano Taliun SA
    Genet Epidemiol; 2023 Jun; 47(4):303-313. PubMed ID: 36821788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-based burden scores identify rare variant associations for 28 blood biomarkers.
    Aldisi R; Hassanin E; Sivalingam S; Buness A; Klinkhammer H; Mayr A; Fröhlich H; Krawitz P; Maj C
    BMC Genom Data; 2023 Sep; 24(1):50. PubMed ID: 37667186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
    Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
    Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Risks of Dry Eye Disease Development Using a Genome-Wide Polygenic Risk Score Model.
    Hsu CC; Chuang HK; Hsiao YJ; Chiang PH; Chen SW; Luo WT; Yang YP; Tsai PH; Chen SJ; Hsieh AR; Chiou SH
    Transl Vis Sci Technol; 2024 May; 13(5):13. PubMed ID: 38767906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Utility of 25 Disease and Risk Factor Polygenic Risk Scores for Stratifying Risk of All-Cause Mortality.
    Meisner A; Kundu P; Zhang YD; Lan LV; Kim S; Ghandwani D; Pal Choudhury P; Berndt SI; Freedman ND; Garcia-Closas M; Chatterjee N
    Am J Hum Genet; 2020 Sep; 107(3):418-431. PubMed ID: 32758451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
    Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
    J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
    Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BridgePRS leverages shared genetic effects across ancestries to increase polygenic risk score portability.
    Hoggart CJ; Choi SW; García-González J; Souaiaia T; Preuss M; O'Reilly PF
    Nat Genet; 2024 Jan; 56(1):180-186. PubMed ID: 38123642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FairPRS: adjusting for admixed populations in polygenic risk scores using invariant risk minimization.
    Machado Reyes D; Bose A; Karavani E; Parida L
    Pac Symp Biocomput; 2023; 28():198-208. PubMed ID: 36540977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European women.
    Bafligil C; Thompson DJ; Lophatananon A; Ryan NAJ; Smith MJ; Dennis J; Mekli K; O'Mara TA; Evans DG; Crosbie EJ
    Genet Med; 2022 Sep; 24(9):1847-1856. PubMed ID: 35704044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.